{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T04:59:25Z","timestamp":1790312365100,"version":"4.1.0"},"reference-count":22,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Mol. Sci.","IJMS"],"abstract":"<jats:p>Cancer antigen 15-3 (CA15-3) and carcinoembryonic antigen (CEA) are used alongside clinical and radiologic assessment in metastatic breast cancer, but progression may occur without a preceding increase in either marker. We examined whether this differed according to newly documented anatomical involvement around radiographic progression. We analyzed 4517 radiographic progression events from 1592 patients in the Memorial Sloan Kettering\u2013Clinical History of Real-World Data (MSK-CHORD) breast cancer cohort. A qualifying marker rise was defined as a \u226525% increase in CA15-3 or CEA from the preceding running nadir, occurring more than 30 days after treatment-line initiation and within 90 days before progression. Anatomical associations were estimated using patient-clustered logistic generalized estimating equations. A total of 1650 events (36.5%) occurred without a preceding qualifying rise. This proportion ranged from 24.8% for newly documented liver involvement to 45.1% for central nervous system involvement. Liver involvement was associated with lower odds of progression without a preceding rise (adjusted OR 0.53, 95% CI 0.40\u20130.71), whereas central nervous system involvement was associated with higher odds (OR 1.60, 95% CI 1.19\u20132.14). The associations remained consistent across sensitivity analyses. Thus, among documented radiographic progression events, the frequency of a preceding CA15-3 or CEA rise differed according to newly documented anatomical involvement.<\/jats:p>","DOI":"10.3390\/ijms27198502","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T16:10:31Z","timestamp":1790179831000},"page":"8502","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Anatomical Heterogeneity in Longitudinal CA15-3 and CEA Rises Preceding Metastatic Breast Cancer Progression"],"prefix":"10.3390","volume":"27","author":[{"given":"Zsanett","family":"Szilv\u00e1si","sequence":"first","affiliation":[{"name":"Department of Bioinformatics, Semmelweis University, T\u0171zolt\u00f3 utca 7\u20139, H-1094 Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Borb\u00e1la","family":"Bruszniczky","sequence":"additional","affiliation":[{"name":"Department of Bioinformatics, Semmelweis University, T\u0171zolt\u00f3 utca 7\u20139, H-1094 Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6672-6563","authenticated-orcid":false,"given":"J\u00e1nos Tibor","family":"Fekete","sequence":"additional","affiliation":[{"name":"Department of Bioinformatics, Semmelweis University, T\u0171zolt\u00f3 utca 7\u20139, H-1094 Budapest, Hungary"},{"name":"Institute of Transdisciplinary Discoveries, University of P\u00e9cs Medical School, Szigeti Street 12, H-7624 P\u00e9cs, Hungary"},{"name":"Institute of Molecular Life Sciences, HUN-REN Research Centre for Natural Sciences, Magyar tud\u00f3sok k\u00f6r\u00fatja 2, H-1117 Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1200\/JCO.22.01063","article-title":"Biomarkers for Systemic Therapy in Metastatic Breast Cancer: ASCO Guideline Update","volume":"40","author":"Henry","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.annonc.2026.05.707","article-title":"Metastatic Breast Cancer: ESMO Clinical Practice Guideline for Diagnosis, Treatment and Follow-Up","volume":"37","author":"Barrios","year":"2026","journal-title":"Ann. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cca.2017.04.023","article-title":"The Diagnostic Value of Serum Tumor Markers CEA, CA19-9, CA125, CA15-3, and TPS in Metastatic Breast Cancer","volume":"470","author":"Wang","year":"2017","journal-title":"Clin. Chim. Acta"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"BMT50","DOI":"10.2217\/bmt-2020-0015","article-title":"The Utility of the Tumor Markers CA15.3, CEA, CA-125 and CA19.9 in Metastatic Breast Cancer","volume":"9","author":"Gaughran","year":"2020","journal-title":"Breast Cancer Manag."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.clbc.2022.04.007","article-title":"Elevated CA 15.3 in Newly Diagnosed Breast Cancer: A Retrospective Study","volume":"22","author":"Heylen","year":"2022","journal-title":"Clin. Breast Cancer"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Yilmaz, S., and Yur, M. (2025). CA 15 - 3 May Be a Promising Biomarker for Differentiating Distant Organ Metastasis in Breast Cancer at Initial Diagnosis. BMC Cancer, 26.","DOI":"10.1186\/s12885-025-15463-4"},{"key":"ref_7","first-page":"100402","article-title":"The Utility of Serum Tumor Markers CEA and CA 15-3 for Breast Cancer Prognosis and Their Association with Clinicopathological Parameters","volume":"28","author":"Uygur","year":"2021","journal-title":"Cancer Treat. Res. Commun."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.breast.2020.05.005","article-title":"Clinical Utility of Tumour Marker Velocity of Cancer Antigen 15-3 (CA 15-3) and Carcinoembryonic Antigen (CEA) in Breast Cancer Surveillance","volume":"52","author":"Hing","year":"2020","journal-title":"Breast"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2022-1-3","DOI":"10.7573\/dic.2022-1-3","article-title":"The Prognostic Role of Variations in Tumour Markers (CEA, CA15.3) in Patients with Metastatic Breast Cancer Treated with CDK4\/6 Inhibitors","volume":"11","author":"Sottotetti","year":"2022","journal-title":"Drugs Context"},{"key":"ref_10","first-page":"1963","article-title":"Importance of CEA and CA 15-3 during Disease Progression in Metastatic Breast Cancer Patients","volume":"27","author":"Laessig","year":"2007","journal-title":"Anticancer Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"100203","DOI":"10.1016\/j.esmoop.2021.100203","article-title":"Detection of Secondary Metastatic Breast Cancer by Measurement of Plasma CA 15.3","volume":"6","author":"Heylen","year":"2021","journal-title":"ESMO Open"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1093\/jamia\/ocz148","article-title":"How and When Informative Visit Processes Can Bias Inference When Using Electronic Health Records Data for Clinical Research","volume":"26","author":"Goldstein","year":"2019","journal-title":"J. Am. Med. Inform. Assoc."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/stan.12188","article-title":"Mixed-Effects Models for Health Care Longitudinal Data with an Informative Visiting Process: A Monte Carlo Simulation Study","volume":"74","author":"Gasparini","year":"2020","journal-title":"Stat. Neerl."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"418","DOI":"10.3109\/1354750X.2010.482672","article-title":"Prognostic Role of Serum Cancer Antigen 15-3 in Breast Cancer Patients with Isolated Bone Metastases","volume":"15","author":"Turanli","year":"2010","journal-title":"Biomarkers"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41523-023-00550-1","article-title":"Liquid Biopsy for Brain Metastases and Leptomeningeal Disease in Patients with Breast Cancer","volume":"9","author":"Morganti","year":"2023","journal-title":"npj Breast Cancer"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s12032-023-02047-0","article-title":"Biology of Breast Cancer Brain Metastases and Novel Therapies Targeting the Blood Brain Barrier: An Updated Review","volume":"40","author":"Zhao","year":"2023","journal-title":"Med. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/j.cca.2010.08.039","article-title":"CA 15-3: Uses and Limitation as a Biomarker for Breast Cancer","volume":"411","author":"Duffy","year":"2010","journal-title":"Clin. Chim. Acta"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/s41586-024-08167-5","article-title":"Automated Real-World Data Integration Improves Cancer Outcome Prediction","volume":"636","author":"Jee","year":"2024","journal-title":"Nature"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci. Signal."},{"key":"ref_21","unstructured":"R Core Team (2023). R: A Language and Environment for Statistical Computing, R Foundation for Statistical Computing."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v015.i02","article-title":"The R Package Geepack for Generalized Estimating Equations","volume":"15","author":"Halekoh","year":"2006","journal-title":"J. Stat. Softw."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/19\/8502\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T04:17:31Z","timestamp":1790309851000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/19\/8502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,23]]},"references-count":22,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["ijms27198502"],"URL":"https:\/\/doi.org\/10.3390\/ijms27198502","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,23]]}}}